Financials
- Market Capitalization 190.11 M
- Employee 57
- Founded 2014
- CEO N/A
- Website www.korrobio.com
- Headquarter Delaware, United States
- FIGI BBG00GFMTC38
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3623 | NKTX Nkarta, Inc. - Common Stock | 2.76 USD | +0.36% | +5.34% | +28.97% | +28.37% | 197.68 M USD | ||
| 3631 | ARMP Armata Pharmaceuticals, Inc. Common Stock | 5.30 USD | -1.49% | +6.43% | +15.72% | -35.15% | 197.06 M USD | ||
| 3656 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 68.81 USD | -5.18% | -10.62% | -17.31% | +187.43% | 191.72 M USD | ||
| 3673 | MOLN Molecular Partners AG - American Depositary Shares | 4.50 USD | -3.23% | +4.65% | +5.88% | +16.28% | 181.69 M USD |
Frequently asked questions about Korro Bio, Inc. Common Stock
What is the Korro Bio, Inc. Common Stock stock price today?
The current price of Korro Bio, Inc. Common Stock (KRRO) is 12.91. Over the past 24 hours, the stock has changed by -2.64%. Follow the KRRO chart for real-time price dynamics.
What is the stock ticker of Korro Bio, Inc. Common Stock?
Korro Bio, Inc. Common Stock trades under the ticker KRRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Korro Bio, Inc. Common Stock stock going up?
KRRO has changed by -2.05% over the last week, +25.83% over the last month, and -66.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Korro Bio, Inc. Common Stock?
Korro Bio, Inc. Common Stock currently has a market capitalization of 190.11 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Korro Bio, Inc. Common Stock earnings last quarter?
Last quarter, Korro Bio, Inc. Common Stock reported earnings of -1.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Korro Bio, Inc. Common Stock revenue for the last quarter?
Korro Bio, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Korro Bio, Inc. Common Stock net income for the last quarter?
Korro Bio, Inc. Common Stock reported net income of -18.92 M for the last quarter. The previous quarter showed -19.63 M, which means net income changed by +3.61%.
How many employees does Korro Bio, Inc. Common Stock have?
As of the latest available data, Korro Bio, Inc. Common Stock has 57 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Korro Bio, Inc. Common Stock stock?
You can buy Korro Bio, Inc. Common Stock (KRRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Korro Bio, Inc. Common Stock stock?
Investing in Korro Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KRRO chart and related analysis on metatrader.com as part of your research.